DexCom, Inc. Q1 2026 Financial Results

DexCom, Inc. reported its financial results for the first quarter ended March 31, 2026. Revenue increased by 15% year-over-year to $1.192 billion. U.S. revenue grew 11% and international revenue grew 26%. GAAP operating income was $255.3 million, a significant increase from the previous year. The company expanded the launch of Dexcom G7 and introduced new features to its Stelo platform. DexCom is raising its fiscal year 2026 guidance for Non-GAAP Operating Margin and Adjusted EBITDA Margin, while reiterating guidance for Revenue and Non-GAAP Gross Profit Margin. The company ended the quarter with $2.42 billion in cash, cash equivalents, and marketable securities.